Multiplicative Impact of Adverse Social Determinants of Health on Outcomes in Lupus Nephritis: A Meta‐analysis and Systematic Review
Open Access
- 23 June 2024
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 76 (9) , 1232-1245
Abstract
Objective: Social determinants of health (SDoH) likely contribute to outcome disparities in lupus nephritis (LN). Understanding the overall burden and contribution of each domain could guide future health equity–focused interventions to improve outcomes and reduce disparities in LN. Objectives of this meta‐analysis were to 1) determine the association of overall SDoH and specific SDoH domains on LN outcomes and 2) develop a framework for the multidimensional impact of SDoH on LN outcomes.Methods: We performed a comprehensive search of studies measuring associations between SDoH and LN outcomes. We examined pooled odds of poor LN outcomes including death, end‐stage kidney disease, or cardiovascular disease in patients with and without adverse SDoH. Additionally, we calculated the pooled odds ratios of outcomes by four SDoH domains: individual (eg, insurance), health care (eg, fragmented care), community (eg, neighborhood socioeconomic status), and health behaviors (eg, smoking).Results: Among 531 screened studies, 31 meeting inclusion criteria and 13 with raw data were included in meta‐analysis. Pooled odds of poor outcomes were 1.47‐fold higher in patients with any adverse SDoH. Patients with adverse SDoH in individual and health care domains had 1.64‐fold and 1.77‐fold higher odds of poor outcomes. We found a multiplicative impact of having two or more adverse SDoH on LN outcomes. Black patients with public insurance and fragmented care had 12‐fold higher odds of poor LN outcomes.Conclusion: Adverse SDoH is associated with poor LN outcomes. Having two or more adverse SDoH, specifically in different SDoH domains, had a multiplicative impact leading to worse LN outcomes, widening disparities. imageKeywords
Funding Information
- National Center for Advancing Translational Sciences (Clinical and Translational Science Award, UL1TR002373)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60‐AR‐066464)
- Institute for Clinical and Translational Research, University of Wisconsin, Madison (MSN267532)
This publication has 60 references indexed in Scilit:
- Performance of Modified ALMS and BLISS Criteria with Standard of Care Treatment in Two US Health Care SystemsArthritis Care & Research, 2023
- Association of Area‐Level Heat and Social Vulnerability With Recurrent Hospitalizations Among Individuals With Rheumatic ConditionsArthritis Care & Research, 2022
- Multidisciplinary Lupus Nephritis Clinic Reduces Time to Renal Biopsy and Improves Care QualityACR Open Rheumatology, 2022
- Disease Outcomes and Care Fragmentation Among Patients With Systemic Lupus ErythematosusArthritis Care & Research, 2016
- Incidence of End‐Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus RegistryArthritis Care & Research, 2015
- Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End‐Stage Renal Disease Due to Lupus NephritisArthritis Care & Research, 2015
- Variation in initial kidney replacement therapy for end‐stage renal disease due to lupus nephritis in the United StatesArthritis Care & Research, 2011
- Socioeconomic Status in Health ResearchJAMA, 2005
- Factors associated with refractory renal disease in patients with systemic lupus erythematosus: The role of patient nonadherenceArthritis & Rheumatism, 2000
- Clinical Prognostic Factors in Lupus NephritisArchives of internal medicine (1960), 1992